Home » Drug Information » New Medical Therapies™
August 26, 2002
In an open label study of topical nitroglycerin (NTG) in subjects with vulvodynia, results showed significant decreases in pain intensity and frequency of overall pain. Improvement in pain was reported by 31 of the 34 female subjects. Cellegy Pharmaceuticals, who sponsored the study, plans to develop a topical NTG product for the vulvodynia indication.